Media - Abzena


MHC Associated Peptide Proteomics

Case Study MAPPs for Vaccine Design To identify MHC class I presented antigens derived from influenza strain H1N1, two[...]



The Bioprocessing Summit

13 August 2018

The Bioprocessing Summit convenes more than 1,000 international bioprocess professionals to share practical solutions for[...] Read more

ON Helix

10 July 2018

ON Helix is One Nucleus’ translational research conference for the Life Sciences industry. ON Helix is a two-day event[...] Read more


Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids

Natural products have been used for many medicinal purposes for centuries. Antibody drug conjugates (ADCs) have utilized[...] Read more


Abzena and Telix sign strategic manufacturing and bioconjugation agreement

Cambridge, UK and Melbourne, Australia, 2 July 2018 – Abzena plc (AIM: ABZA, ‘Abzena’), the life sciences group[...] Read more

Funding update: Seeking to monetise royalty-bearing ABZENA Inside products

Cambridge, UK, 14 June 2018 – Abzena plc (AIM: ABZA, ‘Abzena’ or the ‘Company’, and[...] Read more


We’re changing the way we brand our businesses

To provide our Partners with a single identity for the services and technologies offered across Antitope, PacificGMP,[...] Read more

Interested in our services? Get In Touch